Ad is loading...
MENU

NRBO NeuroBo Pharmaceuticals Forecast, Technical & Fundamental Analysis

a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

Industry Biotechnology
NRBO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
NRBO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NRBO is expected to report earnings to rise 33.33% to -11 cents per share on March 29

NeuroBo Pharmaceuticals NRBO Stock Earnings Reports
Q4'23
Est.
$-0.12
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.11
Q1'23
Beat
by $0.53
Q4'22
Beat
by $6.13
The last earnings report on November 13 showed earnings per share of -9 cents, beating the estimate of -10 cents. With 40.83K shares outstanding, the current market capitalization sits at 19.13M.
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
545 Concord Avenue
Phone
+1 857 702-9600
Employees
8
Web
https://www.neurobopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXT55.490.20
+0.36%
Crane NXT Co
CCL24.31N/A
N/A
Carnival Corp
PRLB37.47-0.56
-1.47%
Proto Labs
GASS5.74-0.18
-3.04%
StealthGas
CGTX0.46-0.05
-9.85%
Cognition Therapeutics

NRBO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRBO has been loosely correlated with TCRT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NRBO jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRBO
1D Price
Change %
NRBO100%
-7.11%
TCRT - NRBO
50%
Loosely correlated
-10.59%
ARGX - NRBO
45%
Loosely correlated
-5.18%
BLUE - NRBO
37%
Loosely correlated
-11.53%
SYRE - NRBO
37%
Loosely correlated
-6.62%
AKRO - NRBO
32%
Poorly correlated
-5.61%
More